These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 32328992

  • 61. Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines.
    Vesikari T, Joensuu J, Baer M, Käyhty H, Olander RM, Sormunen H, Miettinen A, Ward RL, Guillot T.
    Acta Paediatr; 1999 May; 88(5):513-20. PubMed ID: 10426173
    [Abstract] [Full Text] [Related]

  • 62. MMR lowers infection-related hospital admissions in children.
    Tanday S.
    Lancet Respir Med; 2014 Apr; 2(4):263. PubMed ID: 24949501
    [No Abstract] [Full Text] [Related]

  • 63. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
    Pichichero ME, Bernstein H, Blatter MM, Schuerman L, Cheuvart B, Holmes SJ, 085 Study Investigators.
    J Pediatr; 2007 Jul; 151(1):43-9, 49.e1-2. PubMed ID: 17586189
    [Abstract] [Full Text] [Related]

  • 64. Community health worker intervention improves early childhood vaccination rates: results from a propensity-score matching evaluation.
    Wightman P, McCue K, Sabo S, Annorbah R, Jiménez D, Pilling V, Butler M, Celaya MF, Rumann S.
    BMC Public Health; 2022 Oct 04; 22(1):1854. PubMed ID: 36195944
    [Abstract] [Full Text] [Related]

  • 65. A Randomized Controlled Study of a Fully Liquid DTaP-IPV-HB-PRP-T Hexavalent Vaccine for Primary and Booster Vaccinations of Healthy Infants and Toddlers in Latin America.
    López P, Arguedas Mohs A, Abdelnour Vásquez A, Consuelo-Miranda M, Feroldi E, Noriega F, Jordanov E, B Chir S, Zambrano B.
    Pediatr Infect Dis J; 2017 Nov 04; 36(11):e272-e282. PubMed ID: 28719500
    [Abstract] [Full Text] [Related]

  • 66. Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine.
    Daley MF, Yih WK, Glanz JM, Hambidge SJ, Narwaney KJ, Yin R, Li L, Nelson JC, Nordin JD, Klein NP, Jacobsen SJ, Weintraub E.
    Vaccine; 2014 May 23; 32(25):3019-24. PubMed ID: 24699471
    [Abstract] [Full Text] [Related]

  • 67. Chronically ill adolescents are also incompletely vaccinated: A cross-sectional study in France.
    Gras-Le Guen C, Legrand A, Caquard M, Micaelli X, Picherot G, Lacroix S, Volteau C, Launay E.
    Vaccine; 2017 Aug 24; 35(36):4707-4712. PubMed ID: 28760611
    [Abstract] [Full Text] [Related]

  • 68. A fully liquid diphtheria-tetanus-five component acellular pertussis-inactivated poliomyelitis--Haemophilus influenzae type b conjugate vaccine: immunogenicity and safety of primary vaccination in Taiwanese infants.
    Lin TY, Wang YH, Chang LY, Huang YC, Kao HT, Lin PY, Lu HK, Chavand P, Ortiz E.
    Int J Infect Dis; 2007 Mar 24; 11(2):129-36. PubMed ID: 16762579
    [Abstract] [Full Text] [Related]

  • 69. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
    Silfverdal SA, Assudani D, Kuriyakose S, Van Der Meeren O.
    Hum Vaccin Immunother; 2014 Mar 24; 10(10):2795-8. PubMed ID: 25483640
    [Abstract] [Full Text] [Related]

  • 70. Safety and immunogenicity of two formulations of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae conjugate-hepatitis B vaccine in 15 to 18-month-old children.
    Halperin SA, Langley JM, Hesley TM, Zappacosta PS, Radley D, Smith B, Hoffenbach A, Boslego J, Silber JL.
    Hum Vaccin; 2005 Mar 24; 1(6):245-50. PubMed ID: 17012871
    [Abstract] [Full Text] [Related]

  • 71. 13-valent pneumococcal conjugate vaccine given with meningococcal C-tetanus toxoid conjugate and other routine pediatric vaccinations: immunogenicity and safety.
    Martinón-Torres F, Gimenez-Sanchez F, Gurtman A, Bernaola E, Diez-Domingo J, Carmona A, Sidhu M, Sarkozy DA, Gruber WC, Emini EA, Scott DA, 3007 Study Group.
    Pediatr Infect Dis J; 2012 Apr 24; 31(4):392-9. PubMed ID: 22301472
    [Abstract] [Full Text] [Related]

  • 72. Comparison of the tolerability of an acellular pertussis-containing vaccine given as the fifth booster dose in differently primed children.
    Kemmeren JM, Timmer SS, van der Maas NA, de Melker HE.
    Vaccine; 2011 Jun 10; 29(26):4373-7. PubMed ID: 21514347
    [Abstract] [Full Text] [Related]

  • 73. Comparison of the reactogenicity of three different immunization schedules including diphtheria, tetanus, pertussis, Haemophilus influenza b and polio vaccine in Turkey.
    Beyazova U, Yüksel N, Aksakal FN, Camurdan AD.
    Trans R Soc Trop Med Hyg; 2013 Jul 10; 107(7):438-43. PubMed ID: 23720155
    [Abstract] [Full Text] [Related]

  • 74. Influences on immunization rates: Vaccination coverage of mumps, measles, rubella and varicella before and after the STIKO intervention 2011 - A retrospective study.
    Sanftenberg L, Schrörs HJ, Schelling J.
    Vaccine; 2016 Jul 25; 34(34):3938-41. PubMed ID: 27318420
    [Abstract] [Full Text] [Related]

  • 75. Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course in healthy Korean infants: phase III, randomized study.
    Kim KH, Kim CS, Kim HM, Kim JD, Ma SH, Kim DH, Hwang PH, Han JW, Lee TJ, Kim JH, Karkada N, Mesaros N, Sohn WY, Kim JH.
    Hum Vaccin Immunother; 2019 Jul 25; 15(2):317-326. PubMed ID: 30431387
    [Abstract] [Full Text] [Related]

  • 76. Combining tabular, rule-based, and procedural knowledge in computer-based guidelines for childhood immunization.
    Miller PL, Frawley SJ, Sayward FG, Yasnoff WA, Duncan L, Fleming DW.
    Comput Biomed Res; 1997 Jun 25; 30(3):211-31. PubMed ID: 9281329
    [Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.